S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
OTCMKTS:RHHVF

Roche Price Target, Predictions & Analyst Ratings

$372.00
-2.99 (-0.80 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$358.00
$375.00
50-Day Range
$362.50
$409.99
52-Week Range
$308.57
$411.44
Volume132 shs
Average Volume5,586 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Roche (OTCMKTS:RHHVF) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 8 Analyst Ratings

Analyst Price Target Consensus

$0.00

High PT$0.00
Average PT$0.00
Low PT$0.00
TypeCurrent
9/26/20 to 9/26/21
1 Month Ago
8/27/20 to 8/27/21
3 Months Ago
6/28/20 to 6/28/21
1 Year Ago
9/27/19 to 9/26/20
Consensus Rating
Buy
Buy
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
9 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Price Target UpsideN/AN/AN/AN/A
Get Roche Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RHHVF and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Roche (OTCMKTS:RHHVF) vs. Its Competitors

TypeRocheMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.73
2.56
Consensus RatingBuyBuyBuy
Price Target Upside126.05% Upside7.85% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
30
71.43%
Underperform Votes
12
28.57%
Avg. Outperform Votes
177
67.30%
Avg. Underperform Votes
86
32.70%
Avg. Outperform Votes
829
69.49%
Avg. Underperform Votes
364
30.51%

Roche (OTCMKTS:RHHVF) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/17/2021JPMorgan Chase & Co.
Reiterated RatingHold
9/15/2021Deutsche Bank Aktiengesellschaft
Reiterated RatingBuy
9/7/2021Jefferies Financial Group
Reiterated RatingBuy
8/10/2021Sanford C. Bernstein
Reiterated RatingBuy
6/25/2021The Goldman Sachs Group
Reiterated RatingBuy
4/21/2021Barclays
Reiterated RatingBuy
3/23/2021UBS Group
Reiterated RatingHold
1/8/2021Berenberg Bank
Reiterated RatingHold ➝ Neutral
7/29/2020Credit Suisse Group
Reiterated RatingHold
4/30/2020HSBC
UpgradeHold
4/1/2020Redburn Partners
Simon Baker CFA
UpgradeBuy
2/17/2020Citigroup
Andrew Baum
UpgradeBuy
(Data available from 9/26/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Roche (OTCMKTS:RHHVF) Analyst Ratings Frequently Asked Questions

What is Roche's consensus rating?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Roche stock is Buy based on the current 3 hold ratings and 5 buy ratings for RHHVFthe . Learn more on RHHVF's analyst rating history

Do Wall Street analysts like Roche more than its competitors?

Analysts like Roche stock less than the stock of other Medical companies. The consensus rating score for Roche is 2.63 while the average consensus rating score for medical companies is 2.73. Learn more on how RHHVF compares to other companies

Do MarketBeat users like Roche more than its competitors?

MarketBeat users like Roche stock more than the stock of other Medical companies. 71.43% of MarketBeat users gave Roche an outperform vote while medical companies recieve an average of 67.30% outperform votes by MarketBeat users.

What analysts cover Roche?

This page was last updated on 9/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.